Shots: The approval is based on two P-III studies POLARIS-1 and POLARIS-4 assessing Vosevi in patients with HCV genotype 1-6 with or without compensated cirrhosis who had failed prior DAA […]readmore
Tags : Hepatitis C
Shots: The Louisiana Department of Health signs a 5 years agreement with Asegua to implement the innovative payment model for the treatment of Hepatitis C and to improve the health […]readmore
Shots: The approval follows the clinical study results assessing Mavyret (glecaprevir & pibrentasvir) in 47 children aged 12-17 yrs. with genotype 1, 2, 3 or 4 HCV infection without/mild Cirrhosis […]readmore